AGC
ORIAW

Angelo Gordon & Co’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Angelo Gordon & Co’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-60,000
Closed -$614K – 117
2023
Q1 		$614K Buy
+60,000
New +$15.7K 0.15% 55

Angelo Gordon & Co's ORIAW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q1 2023, closing a stake of 60,000 shares — an estimated $15.7K sold.

Angelo Gordon & Co first reported a position in ORIAW in Q3 2021 and held it in 6 quarters. The position peaked at $603K in Q4 2022. 25 funds tracked by Wall St. Rank hold ORIAW as of Q1 2023.

  • Angelo Gordon & Co reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Angelo Gordon & Co sold 60,000 Orion Biotech Opportunities Corp. Warrant shares in Q1 2023, an estimated $15.7K.
  • Angelo Gordon & Co first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 6 quarters.
  • Angelo Gordon & Co's Orion Biotech Opportunities Corp. Warrant position peaked at $603K in Q4 2022.
  • 25 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.